Navigation Links
U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
Date:9/1/2009

MOUNTAIN VIEW, Calif., Sept. 1 /PRNewswire/ -- The maturity of the U.S. compression therapy market is necessitating the introduction of advanced technologies to break the growth plateau. Manufacturers are using the concept of evidence-based medicine to educate physicians and encourage the adoption of new technologies. Growing health awareness among consumers has spurred the demand for early diagnosis and preventive approaches. This, coupled with the increasing incidence of obesity and chronic wounds, is fuelling the compression therapy market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), U.S. Compression Therapy Market, finds that market earned revenues of over $673.7 million in 2008, and estimates this to reach $1.16 billion in 2015. The study covers market dynamics, revenue forecast analysis, and patient population trends for the static and dynamic compression therapy segments.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Johanna Haynes at johanna.haynes@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

Chronic venous disease (CVD) of the lower extremity affects an estimated 40 percent of the U.S. population, accounting to 4.6 million lost working days every year.

"Compression therapy has evolved to be the mainstay of treatment and management of chronic venous insufficiency and venous ulcers," explains Frost & Sullivan Research Analyst Archana Swathy. "Currently, compression therapy is being aggressively adopted in the prevention of post-operative deep vein thrombosis (DVT)."

As hospitals strive to control costs through early discharges, the demand for home-use therapy products is on the rise. Consumers are displaying a preference for multi-functional, high-quality products that also offer the benefits of reduced treatment time. The current market need is patient-friendly products that suit patient lifestyles and afford better compliance to therapy. The development of mobile compression systems will improve market prospects, as they will cater to consumers who intend to stay active even while undergoing therapy.

Aesthetically pleasing and easy-to-use compression garments will go a long way in enabling patient compliance to treatment. There also exists a pressing need to establish clinical evidence that highlights the advantages of intermittent pneumatic compression (IPC), in comparison with other treatment modalities. This approach would be beneficial in enhancing market penetration of dynamic compression products.

"There is a significant lack of differentiation among compression therapy products currently available in the market," observes Archana. "The need for highly distinctive products should ideally result in manufacturers developing compact portable devices that would significantly enhance the healing process."

The lack of sufficient awareness among healthcare practitioners about the significance of new compression technologies is restraining market progression. Building awareness among physicians and care providers regarding the benefits afforded by dynamic compression therapy, such as cost effectiveness and clinical efficiency, is vital for the growth of innovative technologies.

U.S. Compression Therapy Market is part of the Medical Devices Growth Partnership Service program, which also includes research in the following markets: U.S. Hip Implant Market, U.S. and Western Europe Adhesion Prevention Products Market, U.S. Soft Tissue Repair Markets - Meniscus and Cartilage, Cardiovascular Business Digest - U.S. Heart Valve Market, and U.S. Infusion Pumps Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

                         U.S. Compression Therapy Market
                                       N5D4

    Contact:
    Johanna Haynes
    Corporate Communications - North America
    P: 210.247.3870
    F: 210.348.1003
    E: johanna.haynes@frost.com

    Jake Wengroff
    Corporate Communications - North America
    P: 210. 247.3806
    F: 210.348.1003
    E: jake.wengroff@frost.com

   http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Surgery, Sham Equal in Treating Compression Fracture Pain
2. Samplify Systems Announces Next Generation Signal-Compression Technology, Prism 3.0
3. Spinal Decompression Therapy Offers Hope for Back Pain
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. Compression Stockings Offer Little Benefit After Stroke
6. Samplify Rolls Production Quantities of Its SAM1600 Analog/Digital Converters with Real-Time Data Compression
7. Syndication Inc. Seeks Director of Marketing for Sy-Med Decompression Centers; BOD Considers Adding a Green Energy New Company Subsidiary to its Ranks
8. Samplify Systems Announces Availability of Worlds First 16-channel, 12-bit, 65 Msps A/D Converter With Integrated Real-Time Data Compression
9. New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors
10. Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology
11. Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Milford, NJ (PRWEB) , ... December 02, 2016 , ... ... Nothing Water has some unique properties including its unmatched natural purity of just 6 ... as clean and crisp. , Nothing Water has been available in several ShopRite and ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 ... the National Family Partnership and the Drug Enforcement Administration as part of the National ... the 10 winning schools who decorated their campuses with this year’s Red Ribbon Week ...
(Date:11/30/2016)... PALMYRA, Wisconsin (PRWEB) , ... November 30, 2016 ... ... inclusion in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of ... consecutive year on the list, having ranked from 2008-2016. In addition, Standard Process ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... and stylish design wanted by today’s consumers at an affordable price, is now ... says the new watch is “a game changer” when it comes to the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... in the ECG Cables And ECG Leadwires Market owing to ... devices. On the other hand, the Asia-Pacific ... rate during the forecast period. The market players ... plc ( Ireland ), Koninklijke Philips N.V. ( ... ( China ), held major share of the ...
(Date:12/2/2016)... PUNE, India , December 2, 2016 /PRNewswire/ ... research report "In Vitro Diagnostics/IVD Market by Product ... Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious ... the global market is valued at USD 60.22 ... grow at a CAGR of 5.5% during the ...
(Date:12/2/2016)... On Thursday, December 1st 2016, ... research, development and innovation in the biopharmaceutical industry at ... in the presence of Sergey Tsyb, Vice Minister of ... , Natalia Sanina, First Vice Chairman of the ... of Roszdravnadzor, National Service of Control in Healthcare, Sergey ...
Breaking Medicine Technology: